Effect of Transdermal Estradiol and Insulin-like Growth Factor-1 on Bone Endpoints of Young Women With Anorexia Nervosa.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
16 06 2021
Historique:
received: 11 09 2020
pubmed: 12 3 2021
medline: 5 10 2021
entrez: 11 3 2021
Statut: ppublish

Résumé

Anorexia nervosa (AN) is prevalent in adolescent girls and is associated with bone impairment driven by hormonal alterations in nutritional deficiency. To assess the impact of estrogen replacement with and without recombinant human insulin-like growth factor-1 (rhIGF-1) administration on bone outcomes. Double-blind, randomized, placebo-controlled 12-month longitudinal study. Seventy-five adolescent and young adult women with AN age 14 to 22 years. Thirty-three participants completed the study. Transdermal 17-beta estradiol 0.1 mg/day with (i) 30 mcg/kg/dose of rhIGF-1 administered subcutaneously twice daily (AN-IGF-1+) or (ii) placebo (AN-IGF-1-). The dose of rhIGF-1 was adjusted to maintain levels in the upper half of the normal pubertal range. Bone turnover markers and bone density, geometry, microarchitecture, and strength estimates. Over 12 months, lumbar areal bone mineral density increased in AN-IGF-1- compared to AN-IGF-1+ (P = 0.004). AN-IGF-1+ demonstrated no improvement in areal BMD in the setting of variable compliance to estrogen treatment. Groups did not differ for 12-month changes in bone geometry, microarchitecture, volumetric bone mineral density (vBMD), or strength (and results did not change after controlling for weight changes over 12 months). Both groups had increases in radial cortical area and vBMD, and tibia cortical vBMD over 12 months. Levels of a bone resorption marker decreased in AN-IGF-1- (P = 0.042), while parathyroid hormone increased in AN-IGF-1+ (P = 0.019). AN-IGF-1- experienced irregular menses more frequently than did AN-IGF-1+, but incidence of all other adverse events did not differ between groups. We found no additive benefit of rhIGF-1 administration for 12 months over transdermal estrogen replacement alone in this cohort of young women with AN.

Identifiants

pubmed: 33693703
pii: 6161507
doi: 10.1210/clinem/dgab145
pmc: PMC8427708
doi:

Substances chimiques

Biomarkers 0
Estrogens 0
Estradiol 4TI98Z838E
Insulin-Like Growth Factor I 67763-96-6

Types de publication

Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2021-2035

Subventions

Organisme : NICHD NIH HHS
ID : T32 HD007184
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK062249
Pays : United States
Organisme : NIDDK NIH HHS
ID : K23 DK115903
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK040561
Pays : United States
Organisme : NHLBI NIH HHS
ID : K24 HL092902
Pays : United States

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Trends Endocrinol Metab. 2012 Nov;23(11):576-81
pubmed: 22595550
J Bone Miner Res. 2014 Jan;29(1):151-7
pubmed: 23744513
Einstein (Sao Paulo). 2014 Apr;12(2):175-80
pubmed: 25003922
Diabetes Care. 1990 Apr;13(4):401-11
pubmed: 2318100
J Clin Endocrinol Metab. 2002 Jun;87(6):2883-91
pubmed: 12050268
J Clin Endocrinol Metab. 2014 Apr;99(4):1322-9
pubmed: 24456286
J Pediatr. 1952 Apr;40(4):423-41
pubmed: 14918032
Arch Gen Psychiatry. 2002 Jun;59(6):545-52
pubmed: 12044197
J Clin Endocrinol Metab. 2008 Apr;93(4):1231-7
pubmed: 18089702
J Clin Endocrinol Metab. 2008 Apr;93(4):1292-7
pubmed: 18089697
J Clin Endocrinol Metab. 2007 Jun;92(6):2046-52
pubmed: 17356044
J Clin Endocrinol Metab. 2005 Jun;90(6):3179-85
pubmed: 15784715
J Bone Miner Res. 1995 May;10(5):711-5
pubmed: 7639106
J Clin Endocrinol Metab. 2021 Jun 16;106(7):2021-2035
pubmed: 33693703
J Bone Miner Res. 2020 Feb;35(2):248-260
pubmed: 31603998
Endocrinology. 2002 Feb;143(2):627-35
pubmed: 11796519
J Clin Endocrinol Metab. 1999 Dec;84(12):4489-96
pubmed: 10599707
J Pediatr Adolesc Gynecol. 2002 Jun;15(3):135-43
pubmed: 12106749
J Adolesc Health. 2019 Mar;64(3):305-310
pubmed: 30819332
J Clin Endocrinol Metab. 1989 Mar;68(3):548-54
pubmed: 2493036
J Clin Endocrinol Metab. 2012 Jun;97(6):2124-33
pubmed: 22496496
J Clin Endocrinol Metab. 2013 May;98(5):1923-9
pubmed: 23509107
Endocrinology. 1990 Oct;127(4):1804-10
pubmed: 2401235
Br J Sports Med. 2019 Feb;53(4):229-236
pubmed: 30301734
Arch Gen Psychiatry. 2011 Jul;68(7):714-23
pubmed: 21383252
J Adolesc Health. 2019 Oct;65(4):462-468
pubmed: 31227390
Osteoporos Int. 2017 Apr;28(4):1255-1263
pubmed: 27909781
J Clin Endocrinol Metab. 2002 Sep;87(9):4177-85
pubmed: 12213868
Bone. 2018 Jan;106:61-68
pubmed: 28694162
J Bone Miner Res. 2011 Oct;26(10):2430-8
pubmed: 21698665
J Clin Endocrinol Metab. 2002 Nov;87(11):4935-41
pubmed: 12414853
J Clin Endocrinol Metab. 2003 Dec;88(12):5615-23
pubmed: 14671143
Pediatrics. 2002 Jan;109(1):45-60
pubmed: 11773541
J Clin Endocrinol Metab. 2019 May 1;104(5):1449-1458
pubmed: 30476179
J Clin Endocrinol Metab. 2007 Jun;92(6):2087-99
pubmed: 17311856
J Clin Endocrinol Metab. 2004 Oct;89(10):4972-80
pubmed: 15472193
Bone. 2009 Sep;45(3):493-8
pubmed: 19523548
J Adolesc Health. 2017 Feb;60(2):229-232
pubmed: 27939877

Auteurs

Vibha Singhal (V)

Neuroendocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Division of Pediatric Endocrinology, Massachusetts General Hospital for Children and Harvard Medical School, Boston, MA, USA.

Amita Bose (A)

Neuroendocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Meghan Slattery (M)

Neuroendocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Melanie S Haines (MS)

Neuroendocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Mark A Goldstein (MA)

Division of Adolescent Medicine, Massachusetts General Hospital for Children and Harvard Medical School, Boston, MA, USA.

Nupur Gupta (N)

Division of Adolescent Medicine, Massachusetts General Hospital for Children and Harvard Medical School, Boston, MA, USA.

Kathryn S Brigham (KS)

Division of Adolescent Medicine, Massachusetts General Hospital for Children and Harvard Medical School, Boston, MA, USA.

Seda Ebrahimi (S)

Cambridge Eating Disorders Center, Cambridge, MA, USA.

Kristin N Javaras (KN)

Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
Division of Women's Mental Health, McLean Hospital, Belmont, MA, USA.

Mary L Bouxsein (ML)

Division of Endocrinology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Kamryn T Eddy (KT)

Eating Disorders Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Karen K Miller (KK)

Neuroendocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

David Schoenfeld (D)

Biostatistics Center at Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Anne Klibanski (A)

Neuroendocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Madhusmita Misra (M)

Neuroendocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Division of Pediatric Endocrinology, Massachusetts General Hospital for Children and Harvard Medical School, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH